Results 151 to 160 of about 120,185 (315)

Central blood volume in cirrhosis [PDF]

open access: yes, 1993
Bendtsen, Flemming   +2 more
core   +1 more source

Ascitic fluid analysis for the differentiation of malignancy related and nonmalignant ascites [PDF]

open access: yes, 1991
The authors tried to differentiate malignancy-related from nonmalignant ascites with a sequence of sensitive followed by specific ascitic-fluid parameters. There were four results of this study. First, of nine parameters investigated in a first series of
Gerbes, Alexander L.   +4 more
core  

Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation

open access: yesLiver Transplantation, EarlyView., 2022
Abstract Hepatopulmonary syndrome (HPS) is associated with increased waitlist mortality in liver transplantation (LT) candidates. Children with HPS are granted Model for End‐Stage Liver Disease (MELD)/Pediatric End‐Stage Liver Disease (PELD) exception points for waitlist prioritization in the United States based on criterion developed for adults.
Muhammad H. Raza   +8 more
wiley   +1 more source

Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis [PDF]

open access: yes, 1986
Gerbes, Alexander L.   +3 more
core   +1 more source

The Adjunctive Efficacy of Fuzheng Huayu Tablet on Portal Hypertension with HBV Related Cirrhosis: A Protocol for a Multicenter Randomized Controlled Trial

open access: yesOpen Access Journal of Clinical Trials
Zhengxin Li,1 Yanan Guo,1,2 Jihan Huang,2 Jing Lv,1 Chenghai Liu1,3,4 1Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China; 2Shanghai University of
Li Z, Guo Y, Huang J, Lv J, Liu C
doaj  

Albumin Restores Endothelial Cell Mitochondrial Morphology in Patients With Decompensated Cirrhosis. [PDF]

open access: yesLiver Int
Fischer SE   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy